Overview
- 75 inspections across 71 sites are on record.
- 252 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-05-12.
At a glance
Inspections
75
Sites
71
Observations
252
Career since
Oct 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Intas Pharmaceuticals Limited | 12 May 2023 | Human Drugs | On file |
| TTY Biopharm Company Limited Lioudu Factory | 30 Aug 2022 | Human Drugs | On file |
| Abryl Laboratories Private Limited | 22 Jan 2022 | Human Drugs | On file |
| DR.REDDY'S LABORATORIES LIMITED | 29 Oct 2021 | Human Drugs | On file |
| Mylan Laboratories Limited | 17 Sep 2021 | Human Drugs | On file |
Sites inspected
Intas Pharmaceuticals LimitedAhmedabad, India1 insp.
TTY Biopharm Company Limited Lioudu FactoryKeelung City, Taiwan1 insp.
Abryl Laboratories Private LimitedDera Bassi SAS Nagar, India1 insp.
DR.REDDY'S LABORATORIES LIMITEDVisakhapatnam, India1 insp.
Mylan Laboratories LimitedHosur, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Veronica Fuentes6 shared
Justin A Boyd3 shared
Dipesh K Shah3 shared
Carl A Huffman3 shared
Thomas J Arista2 shared
Wayne D Mcgrath2 shared
Robert J Ham2 shared
Michele Perry-Williams2 shared
Rita K Vick1 shared
Arsen Karapetyan1 shared
Full investigator report
Get the verbatim findings behind Rita K Kabaso's 252 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site